LBA4Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC)
Untch, M, Geyer, C E, Huang, C, Loibl, S, Wolmark, N, Mano, M S, von Minckwitz, G, Brufsky, A, Pivot, X, Polikoff, J, Fontana, A, Kaufman, B, Alcedo, J C, Boulet, T, Liu, H, Song, C, Mamounas, E PVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz446.003
Date:
November, 2019
Fichier:
PDF, 104 KB
2019
File converter
Plus de résultats de recherche
More benefits 
